MedPath

DENVER RESEARCH INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

Collaborative Care to Alleviate Symptoms and Adjust to Illness in Chronic Heart Failure (CASA) Trial

Not Applicable
Completed
Conditions
Chronic Heart Failure
First Posted Date
2012-12-03
Last Posted Date
2017-08-01
Lead Sponsor
Denver Research Institute
Target Recruit Count
317
Registration Number
NCT01739686
Locations
🇺🇸

University of Colorado Hospital, Aurora, Colorado, United States

🇺🇸

Denver Health, Denver, Colorado, United States

🇺🇸

VA Eastern Colorado Health Care System(ECHCS), Denver, Colorado, United States

Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance

Phase 4
Conditions
Impaired Glucose Tolerance
Interventions
Drug: Placebo
First Posted Date
2008-08-12
Last Posted Date
2008-08-12
Lead Sponsor
Denver Research Institute
Target Recruit Count
60
Registration Number
NCT00733174
Locations
🇺🇸

South Federal Family Practice, Denver, Colorado, United States

Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair

Terminated
Conditions
Traumatic Brain Injury
First Posted Date
2006-06-14
Last Posted Date
2011-03-24
Lead Sponsor
Denver Research Institute
Registration Number
NCT00336726

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.